DISCLAIMER
The information and content contained on this webpage is intended to be used or viewed solely in jurisdictions where it is lawful to do so. If you access the broker, analyst or research reports contained herein (Reports), you must inform yourself about, and comply with, applicable laws and regulations, including (without limitation) observing securities laws and regulations in jurisdictions that impose restrictions on the distribution of such Reports.
Reports herein may have been commissioned and paid for by Amplia Therapeutics Limited (Amplia). Where a Report is commissioned and paid for by Amplia, the Report will state that this is the case. Third party consent regarding the publication of the information contained in the Reports has been received by Amplia. The views expressed in the Reports are those of the third party analyst writing the report and no part of the compensation received by the analyst is directly related to the inclusion of specific recommendations or opinions.
Amplia, its directors, officers, employees, associates, affiliates and agents disclaim all liability and responsibility for any direct or indirect loss, or damage, which may be incurred by any recipient through any information, omission, error, or inaccuracy contained in the Reports. All information, opinions, conclusions, estimates or recommendations provided in the Reports have been prepared by third parties and Amplia, its directors, officers, employees, associates, affiliates and agents make no representation or warranty as to the accuracy, completeness, or reliability of information prepared by third parties, including any price target, earnings forecast or other statements (including forward-looking statements) about Amplia’s business activities.
To the extent any recommendations or statements of opinion or fact made in the Reports may constitute financial advice, they constitute general information and not personal financial advice in any form. As such, any recommendations or statements do not take into account the financial circumstances, investment objectives, tax implications, or any specific requirements of the recipient. Recipients of information should not act on any recommendation without first taking appropriate steps to verify the information in the Reports, consulting their independent investment advisor in order to ascertain whether the recommendation (if any) is appropriate, having regard to their investment objectives, financial situation and particular needs. Providing access to the Reports should not be construed as investment advice or a solicitation to buy or sell any security or product, or to engage in or refrain from engaging in any transaction by Amplia.
The information provided may include projections, targets, opinions, forecasts and/or estimates which constitute forward-looking statements. These expressed beliefs of future performance, events, results, or returns may not eventuate and as such no guarantee of these future scenarios is given or implied by Amplia. The past performance of Amplia cannot be relied upon as a guide to its future performance.
Each Report will only be current as at the date of the relevant Report, and as such, the Reports themselves may be subject to change. Amplia accepts no responsibility to update any person regarding any inaccuracy, omission or change in information in the Reports or any other information made available to a person, nor any obligation to furnish the person with any further information.
The Reports do not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States, or for the account or benefit of, any “US Person” (as defined in Regulation S under the US Securities Act of 1933, as amended (US Securities Act)). Any securities described in the Reports have not been, and will not be, registered under the US Securities Act and may not be offered or sold in the United States or to any US Person except in transactions exempt from, or not subject to, the registration of the US Securities Act and applicable US state securities laws. By proceeding to access the Reports, you confirm and agree that you are either (a) not a ‘US Person’ as that term is defined in Regulation S under the US Securities Act, are not in the United States, and are not acting for the account or benefit of a US Person, or (b) a ‘qualified institutional buyer’ as that term is defined in Rule 144A under the US Securities Act.
By proceeding to access the Reports you are confirming and agreeing that your access does not violate applicable laws, including the laws of your home jurisdiction and you have read, understood and accept the disclaimer as outlined above.
